Adipose stem cells from chronic pancreatitis patients improve mouse and human islet survival and function.

Abstract

BACKGROUND:

Chronic pancreatitis has surgical options including total pancreatectomy to control pain. To avoid surgical diabetes, the explanted pancreas can have islets harvested and transplanted. Immediately following total pancreatectomy with islet autotransplantation (TP-IAT), many islet cells die due to isolation and transplantation stresses. The percentage of patients remaining insulin free after TP-IAT is therefore low. We determined whether cotransplantation of adipose-derived mesenchymal stem cells (ASCs) from chronic pancreatitis patients (CP-ASCs) would protect islets after transplantation.

METHODS:

In a marginal mass islet transplantation model, islets from C57BL/6 mice were cotransplanted with CP-ASCs into syngeneic streptozotocin-treated diabetic mice. Treatment response was defined by the percentage of recipients reaching normoglycemia, and by the area under the curve for glucose and c-peptide in a glucose tolerance test. Macrophage infiltration, β-cell apoptosis, and islet graft vasculature were measured in transplanted islet grafts by immunohistochemistry. mRNA expression profiling of 84 apoptosis-related genes in islet grafts transplanted alone or with CP-ASCs was measured by the RT2 Profiler™ Apoptosis PCR Array. The impact of insulin-like growth factor-1 (IGF-1) on islet apoptosis was determined in islets stimulated with cytokines (IL-1β and IFN-γ) in the presence and absence of CP-ASC conditioned medium.

RESULTS:

CP-ASC-treated mice were more often normoglycemic compared to mice receiving islets alone. ASC cotransplantation reduced macrophage infiltration, β-cell death, suppressed expression of TNF-α and Bcl-2 modifying factor (BMF), and upregulated expressions of IGF-1 and TNF Receptor Superfamily Member 11b (TNFRSF11B) in islet grafts. Islets cultured in conditioned medium from CP-ASCs showed reduced cell death. This protective effect was diminished when IGF-1 was blocked in the conditioned medium by the anti-IGF-1 antibody.

CONCLUSION:

Cotransplantation of islets with ASCs from the adipose of chronic pancreatitis patients improved islet survival and islet function after transplantation. The effects are in part mediated by paracrine secretion of IGF-1, suppression of inflammation, and promotion of angiogenesis. ASCs from chronic pancreatitis patients have the potential to be used as a synergistic therapy to enhance the efficacy of islet transplantation following pancreatectomy.

• Authors: Lili Song, Zhen Sun, Do-Sung Kim, Wenyu Gou, Charlie Strange, Huansheng Dong, Wanxing Cui, Gary Gilkeson, Katherine A Morgan, David B Adams, Hongjun Wang
• Journal: Stem cell research & therapy (Stem Cell Res Ther) Vol. 8 Issue 1 Pg. 192 (08 30 2017) ISSN: 1757-6512 [Electronic] England
• PMID: 28854965 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)

Chemical References

• Cytokines
• Inflammation Mediators
• Insulin-Like Growth Factor I

Topics

• Adipose Tissue (cytology)
• Animals
• Apoptosis (genetics)
• Coculture Techniques
• Cytokines (metabolism)
• Gene Expression Profiling
• Humans
• Inflammation Mediators (metabolism)
• Insulin-Like Growth Factor I (metabolism)
• Islets of Langerhans (physiology)
• Islets of Langerhans Transplantation
• Macrophages (metabolism)
• Male
• Mice, Inbred C57BL
• Mice, Inbred NOD
• Mice, SCID
• Pancreatitis, Chronic (parasitology)
• Paracrine Communication
• Stem Cell Transplantation
• Stem Cells (cytology)
• Tissue Survival
• Transplantation, Autologous